Can cognitive enhancers reduce the risk of falls in older people with Mild Cognitive Impairment? A protocol for a randomised controlled double blind trial

BMC Neurology

Volumn 9, Issue , 2009, Pages 42-

  Montero Odasso, Manuel ^a,b   Wells, Jennie L ^a,b   Borrie, Michael J ^a,b   Speechley, Mark ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; PLACEBO; RIVASTIGMINE; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

ABDOMINAL PAIN; AGED; ANOREXIA; ARTICLE; ATTENTION; BEDTIME DOSAGE; BODY EQUILIBRIUM; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG MECHANISM; ELDERLY CARE; FALL RISK ASSESSMENT; FALLING; FOLLOW UP; GAIT; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; INSOMNIA; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING; VULNERABLE POPULATION; COGNITIVE DEFECT; FEMALE; HEALTH SERVICES RESEARCH; MALE; PATIENT SELECTION; TREATMENT OUTCOME;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; CHOLINESTERASE INHIBITORS; CLINICAL PROTOCOLS; COGNITION DISORDERS; COMMUNITY-BASED PARTICIPATORY RESEARCH; DOUBLE-BLIND METHOD; FEMALE; GAIT; HUMANS; INDANS; MALE; PATIENT SELECTION; PIPERIDINES; TREATMENT OUTCOME;

EID: 70349577119     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-9-42     Document Type: Article

References (65)

1. Canadian Study of Health and Aging Working Group Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 1994, 150:899-913. 1486712, 8131123.
2. Third Canadian Consensus Conference on Diagnosis and Treatment of Dementia. , http://www.cccdtd.ca/pdfs/Final_Recommendations_CCCDTD_2007.pdf
3. Thomas VS, Darvesh S, MacKnight C, Rockwood K. Estimating the prevalence of dementia in elderly people: a comparison of the Canadian Study of Health and Aging and National Population Health Survey approaches. Int Psychogeriatr 2001, 13(Supp 1):169-175. 10.1017/S1041610202008116, 11892964.
4. Rosano C, Brach J, Longstreth WT, Newman AB. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology 2006, 26:52-60. 10.1159/000089240, 16254454.
5. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988, 319:1701-1707.
6. Morris JC, Rubin EH, Morris EJ, Mandel SA. Senile dementia of the Alzheimer's type: an important risk factor for serious falls. J Gerontol 1987, 42:412-417.
7. Woollacott M, Shumway-Cook A. Attention and the control of posture and gait: a review of an emerging area of research. Gait Posture 2002, 16:1-14. 10.1016/S0966-6362(01)00156-4, 12127181.
8. Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord 2008, 23:329-342. 10.1002/mds.21720, 2535903, 18058946.
9. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005, 76:1479-1484. 10.1136/jnnp.2004.053561, 1739422, 16227534.
10. Burns A, Zaudig M. Mild cognitive impairment in older people. Lancet 2002, 360:1963-1965. 10.1016/S0140-6736(02)11920-9, 12493278.
11. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308. 10.1001/archneur.56.3.303, 10190820.
12. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005, 352:2379-2388. 10.1056/NEJMoa050151, 15829527.
13. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004, 256:240-246. 10.1111/j.1365-2796.2004.01380.x, 15324367.
14. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 2003, 60:1385-1389. 10.1001/archneur.60.10.1385, 14568808.
15. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001, 58:1985-1992. 10.1001/archneur.58.12.1985, 11735772.
16. Liu-Ambrose TY, Ashe MC, Graf P, Beattie BL, Khan KM. Canadian study of health and aging: study methods and prevalence of dementia. Phys Ther 2008, 88:1482-1491.
17. Hausdorff JM, Yogev G, Springer S, Simon ES, Giladi N. Walking is more like catching than tapping: gait in the elderly as a complex cognitive task. Exp Brain Res 2005, 164:541-548. 10.1007/s00221-005-2280-3, 15864565.
18. Lundin-Olsson L, Nyberg L, Gustafson Y. "Stops walking when talking" as a predictor of falls in elderly people. Lancet 1997, 349:617. 10.1016/S0140-6736(97)24009-2, 9057736.
19. Beauchet O, Dubost V, Gonthier R, Kressig RW. Dual-task-related gait changes in transitionally frail older adults: the type of the walking-associated cognitive task matters. Gerontology 2005, 51:48-52. 10.1159/000081435, 15591756.
20. Ble A, Volpato S, Zuliani G, Guralnik JM, Bandinelli S, Lauretani F, Bartali B, Maraldi C, Fellin R, Ferrucci L. Executive function correlates with walking speed in older persons: the InCHIANTI study. J Am Geriatr Soc 2005, 53:410-415. 10.1111/j.1532-5415.2005.53157.x, 15743282.
21. Bootsma-van der Wiel A, Gussekloo J, de Craen AJ, van Exel E, Bloem BR, Westendorp RG. Walking and talking as predictors of falls in the general population: the Leiden 85-Plus Study. J Am Geriatr Soc 2003, 51:1466-1471. 10.1046/j.1532-5415.2003.51468.x, 14511170.
22. Camicioli R, Howieson D, Lehman S, Kaye J. Talking while walking: the effect of a dual task in aging and Alzheimer's disease. Neurology 1997, 48:955-958.
23. Camicioli R, Bouchard T, Licis L. Dual-tasks and walking fast: Relationship to extra-pyramidal signs in advanced Alzheimer disease. J Neurol Sci 2006, 248:205-209. 10.1016/j.jns.2006.05.013, 16759668.
24. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183-194. 10.1111/j.1365-2796.2004.01388.x, 15324362.
25. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000, 355:225-228. 10.1016/S0140-6736(99)06155-3, 10675135.
26. Montero-Odasso M, Bergman H, Phillips NA, Wong C, Sourial N, Chertkow H. The effect of executive and memory dysfunction in gait performance in a cognitive impairment population. J Am Geriatric Soc 2006, 54:S154.
27. Hausdorff JM. Gait variability: methods, modeling and meaning. J Neuroeng Rehabil 2005, 2:19. 10.1186/1743-0003-2-19, 1185560, 16033650.
28. Herman T, Giladi N, Gurevich T, Hausdorff JM. Gait instability and fractal dynamics of older adults with a "cautious" gait: why do certain older adults walk fearfully?. Gait Posture 2005, 21:178-185. 10.1016/j.gaitpost.2004.01.014, 15639397.
29. Paleacu D, Shutzman A, Giladi N, Herman T, Simon ES, Hausdorff JM. Effects of pharmacological therapy on gait and cognitive function in depressed patients. Clin Neuropharmacol 2007, 30:63-71. 10.1097/01.wnf.0000240949.41691.95, 17414938.
30. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001, 49:664-672. 10.1046/j.1532-5415.2001.49115.x, 11380764.
31. Oliver D, Connelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, Vanoli A, Martin FC, Gosney MA. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ 2007, 334:82. 10.1136/bmj.39049.706493.55, 1767306, 17158580.
32. Shaw FE, Bond J, Richardson DA, Dawson P, Steen IN, McKeith IG, Kenny RA. Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial. BMJ 2003, 326:73. 10.1136/bmj.326.7380.73, 139930, 12521968.
33. Shaw FE. Prevention of falls in older people with dementia. J Neural Transm 2007, 114:1259-1264. 10.1007/s00702-007-0741-5, 17557130.
34. Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D, Ieni J, Richardson S. Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. Arch Neurol 2004, 61:1852-1856. 10.1001/archneur.61.12.1852, 15596605.
35. Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O. Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc 2008, 56:946-947. 10.1111/j.1532-5415.2008.01657.x, 18454755.
36. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000, 123(Pt 9):1767-1783. 10.1093/brain/123.9.1767, 10960043.
37. Bohnen N, Kaufer D, Hendrickson R, Ivanco L, Moore R, DeKosky S. Effects of donepezil on motor function in patients with Alzheimer disease. J Clin Psychopharmacol 2004, 24:354-356. 10.1097/01.jcp.0000126665.88905.6a, 15118497.
38. Montero-Odasso M, Wells J, Borrie M. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc 2009, 57:359-360. 10.1111/j.1532-5415.2009.02085.x, 19207156.
39. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci Med Sci 1995, 50A:M28-M34.
40. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldman D. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991, 34:505-514. 10.1002/art.1780340502, 2025304.
41. Altman RD. Criteria for the classification of osteoarthritis of the knee and hip. Scand J Rheumatol Suppl 1987, 65:31-39. 10.3109/03009748709102175, 3317807.
42. Altman RD, Block DA, Brandt KD, Cooke DV, Greenwald RA, Hochberg MC, Howell DS, Ike RW, Kaplan D, Koopman W. Osteoarthritis: definitions and criteria. Ann Rheum Dis 1990, 49:201. 10.1136/ard.49.3.201-a, 1004025, 2353984.
43. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982, 17:37-49. 10.1016/0022-3956(82)90033-4, 7183759.
44. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988, 24:709-711.
45. Chertkow H. Mild cognitive impairment. Curr Opin Neurol 2002, 15:401-407. 10.1097/00019052-200208000-00001, 12151835.
46. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699. 10.1111/j.1532-5415.2005.53221.x, 15817019.
47. Muir SW, Berg K, Chesworth B, Speechley M. Use of the Berg Balance Scale for predicting multiple falls in community-dwelling elderly people: a prospective study. Phys Ther 2008, 88:449-459.
48. Speechley M, Belfry S, Borrie MJ, Jenkyn KB, Crilly R, Gill DP, McLean S, Stolee P, Vandervoort AA, Jones GR. Risk factors for falling among community-dwelling veterans and their caregivers. Can J Aging 2005, 24:261-274.
49. Hittmair-Delazer M, Semenza C, Denes G. Concepts and facts in calculation. Brain 1994, 117(Pt 4):715-728. 10.1093/brain/117.4.715, 7922459.
50. Verghese J, Kuslansky G, Holtzer R, Katz M, Xue X, Buschke H, Pahor M. Walking while talking: effect of task prioritization in the elderly. Arch Phys Med Rehabil 2007, 88:50-53. 10.1016/j.apmr.2006.10.007, 1894901, 17207675.
51. Myers AM, Powell LE, Maki BE, Holliday PJ, Brawley LR, Sherk W. Psychological indicators of balance confidence: relationship to actual and perceived abilities. J Gerontol A Biol Sci Med Sci 1996, 51:M37-M43.
52. Lord SR, Clark RD, Webster IW. Postural stability and associated physiological factors in a population of aged persons. J Gerontol 1991, 46:M69-M76.
53. Montero-Odasso M, Casas A, Hansen K, Gutmanis I, Wells J, Borrie M. Test-Retest Reliability of Quantitative Gait Analysis in People with Mild Cognitive Impairment. Canadian Journal of Geriatric Medicine & Psychiatry 2007, 10:33-34.
54. Bilney B, Morris M, Webster K. Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait. Gait Posture 2003, 17:68-74. 10.1016/S0966-6362(02)00053-X, 12535728.
55. van Uden CJ, Besser MP. Test-retest reliability of temporal and spatial gait characteristics measured with an instrumented walkway system (GAITRite). BMC Musculoskelet Disord 2004, 5:13. 420245, 15147583, 10.1186/1471-2474-5-13.
56. Youdas JW, Hollman JH, Aalbers MJ, Ahrenholz HN, Aten RA, Cremers JJ. Agreement between the GAITRite walkway system and a stopwatch-footfall count method for measurement of temporal and spatial gait parameters. Arch Phys Med Rehabil 2006, 87:1648-1652. 10.1016/j.apmr.2006.09.012, 17141647.
57. Gill DP, Zou GY, Jones GR, Speechley M. Injurious falls are associated with lower household but higher recreational physical activities in community-dwelling older male veterans. Gerontology 2008, 54:106-115. 10.1159/000116113, 18259094.
58. Gill DP, Jones GR, Zou GY, Speechley M. The Phone-FITT: a brief physical activity interview for older adults. J Aging Phys Act 2008, 16:292-315.
59. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006, (1):CD005593.
60. Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2006, (2):CD001190.
61. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134:663-694.
62. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001, 357:1191-1194. 10.1016/S0140-6736(00)04337-3, 11323066.
63. Tinetti ME, Baker DI, McAvay G, Claus EB, Garrett P, Gottschalk M. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994, 331:821-827. 10.1056/NEJM199409293311301, 8078528.
64. Ganz DA, Higashi T, Rubenstein LZ. Monitoring falls in cohort studies of community-dwelling older people: effect of the recall interval. J Am Geriatr Soc 2005, 53:2190-2194. 10.1111/j.1532-5415.2005.00509.x, 16398908.
65. Hochberg Y, Sharper A. Bonferroni Procedure for Multiple Tests of Significance. Biometrika 1988, 75:800-8002.